Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001628280-25-026864)

Filing Details

Accession Number:: 0001628280-25-026864
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-20 16:51:03
Reporting Period:: 2025-05-16

Filing Date:: 2025-05-20
Accepted Time:: 2025-05-20 16:51:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501697	X4 Pharmaceuticals Inc	XFOR	Biological Products, (No Disgnostic Substances) (2836)	273181608

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1644137	Mark Baldry	C/O X4 Pharmaceuticals, Inc. 61 North Beacon Street 4Th Floor Boston MA 02134	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-16	1,032	$2.48	25,337	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On May 16, 2025, the Reporting Person purchased shares of common stock through the Issuer's Amended and Restated 2017 Employee Stock Purchase Plan at a price of $2.482 per share.